Biotech Insider Alert

Overall Rating

Rating: 1.4/5. From 5 votes.
Please wait...
1.4
Rating from 24 votes
If you’ve subscribed to Biotech Insider Alert, please click the stars below to indicate your rating for this newsletter, and please share any other feedback about your experience using the comment box below.

Investment Performance

Rating from 7 votes
Rating: 1.4/5. From 7 votes.
Please wait...
Your vote
  • 5 Stars 0 Votes
  • 4 Stars 0 Votes
  • 3 Stars 1 Votes
  • 2 Stars 1 Votes
  • 1 Stars 5 Votes

Quality Of Writing/Analysis

Rating from 7 votes
Rating: 1.7/5. From 7 votes.
Please wait...
Your vote
  • 5 Stars 1 Votes
  • 4 Stars 0 Votes
  • 3 Stars 0 Votes
  • 2 Stars 1 Votes
  • 1 Stars 5 Votes

Value For Price

Rating from 5 votes
Rating: 1.0/5. From 5 votes.
Please wait...
Your vote
  • 5 Stars 0 Votes
  • 4 Stars 0 Votes
  • 3 Stars 0 Votes
  • 2 Stars 0 Votes
  • 1 Stars 5 Votes

Customer Service

Rating from 5 votes
Rating: 1.4/5. From 5 votes.
Please wait...
Your vote
  • 5 Stars 0 Votes
  • 4 Stars 0 Votes
  • 3 Stars 0 Votes
  • 2 Stars 2 Votes
  • 1 Stars 3 Votes

Share your thoughts...

7 Comments on "Biotech Insider Alert"

Notify of
avatar

This site uses Akismet to reduce spam. Learn how your comment data is processed.

doclazo
Member
4

Biotech insider alert/Ernie Tremblay. He is hawking the next pharmaceutical cannabis. Any ideas what it may be?

Colin Patton
Guest
0

Biotech Insider is another one of the Money Map Press failures. Fell for the big hype that a biotech stock was set to “explode”. The expectation was that there would be a lot of large pharmaceutical companies lining up to get the technology and patents. The results so far? The $5,000 that I invested in stock is now worth $2,000. Unfortunately, I have followed the recommendations of other Money Map Press services and have lost thousands of dollars. Don’t believe any of the Money Map hype for any of their services. Money Map Press gets your money and you lose.

Add a Topic
605
Add a Topic
5971
Add a Topic
5971
Joe
Guest
0

Well, What is their record for past recommendations?

Colin Patton
Guest
0

Money Map Press will tout their “great record” for making money for their subscribers. But that is not my personal experience.From my experience their prime objective is to make money from new subscribers. I fell big time for the hype and lies to the tune of over $8,000. To add injury to insult I also lost thousands of dollars thanks to their recommendations.

Add a Topic
605
4r86p8s2
Irregular
10

This interests me too, since it looks like the latest all in push by the Money Map Press stable.
Ruth

Add a Topic
605
ralphrides
Member
0

did anyone figure out what Ernie T. is talking about? ”

“a new, highly infectious strain of “Old Man’s Friend” is quietly sweeping the heartland, killing nearly every 10 minutes. The FDA’s DOUBLE-SHOT FINAL DECISION is expected on December 27 and December 28. this tiny company’s CEO has been summoned to a critical meeting with the FDA on November 4. this tiny $27 million company. We’d be looking at revenues of $1.8 billion, a sales surge of 6,600%. If the stock follows, that’d be good enough to turn $10,000 into $660,000.”

Add a Topic
3022
Add a Topic
5971
Susan
Guest
0

Have u duped everyone who has relied on Money Market Press as a valid source of info and pays handsomely for it. When r the hedge funds coming in to raise the price into the $20’s as u say?

Add a Topic
231
wpDiscuz